The recent study, carried out at the Chirurgia Generale Unit in Padova, Italy, involved 238 patients who were treated for colorectal cancer between 2015 and 2019. Among these, 31 patients were regular aspirin users, taking a daily dose of 100 mg.
The findings were promising. Regular use of aspirin was linked to a reduction in nodal metastasis, which is the spread of cancer to lymph nodes, and an increase in tumour-infiltrating lymphocytes. These lymphocytes, including T and B cells, play a crucial role in recognising and destroying cancer cells.
Lynch Syndrome Ireland 